Exercise and Colon Cancer
The COURAGE Trial: Colon Recurrence and Aerobic Exercise: A Feasibility Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Abramson Cancer Center of the University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- histologically confirmed TNM stage II-III CC;
- completed surgical resection and adjuvant chemotherapy (if applicable) within 1-24 months before entering the study;
- ≤120 min/wk of self-reported moderate or vigorous intensity physical activity using the Paffenbarger physical activity questionnaire;
- age ≥18 years;
- written physician approval;
- no additional surgery planned within the 6-month intervention (including colostomy reversal);
- ability to walk unaided for 6-minutes;
- no contraindications to exercise using the PA readiness questionnaire (PAR-Q), unless physician approves participation with specific knowledge of this contraindication.
Exclusion Criteria:
- history of another primary invasive cancer (other than non-melanoma skin-cancer);
- evidence of metastatic CC (i.e., TNM M1);
- planning to receive any additional adjuvant chemotherapy;
- pregnant or breast feeding;
- unable to provide baseline blood sample;
cardiac conditions, including the following:
- myocardial infarction or coronary revascularization procedure within prior 3 months;
- uncontrolled hypertension (systolic ≥180 mmHg or diastolic ≥100 mmHg);
- high-risk or uncontrolled arrhythmias;
- clinically significant valvular disease;
- decompensated heart failure;
- known aortic aneurysm;
- any other condition that may impede testing of the study hypothesis or make it unsafe to engage in the exercise program (determined by the investigative team).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: exercise
aerobic exercise on soluble intercellular adhesion molecules
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
1. The biological efficacy of aerobic exercise on soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular adhesion molecule-1 (sVCAM-1) prognostic biomarkers.
Time Frame: 2 years
|
2 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Exercise adherence, quantified as the percentage of total dose completed relative to the total dose prescribed during the six-month study;
Time Frame: 6 months
|
6 months
|
|
Visceral adipose tissue and anthropometric measures at baseline and six-months;
Time Frame: 6 months
|
6 months
|
|
Fasting insulin measured at baseline and six-months;
Time Frame: six months
|
six months
|
|
Circulating tumor cells measured at baseline and six-months.
Time Frame: six months
|
six months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- UPCC 10214
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.